Journal of Gastrointestinal & Digestive System
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Extraordinary advances in hepatology have occurred that impact the diagnosis and treatment of liver disease.
Effective therapies for hepatitis B and C have been developed and continue to be refined. The treatment
of hepatitis B infection is more complex as more therapeutic options become available. Hepatitis C therapy
continues to evolve with remarkable success. Alcoholic liver disease remains a significant health problem
and nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a health problem of epidemic proportions.
Approaches have been developed to manage the complications of cirrhosis and hepatocellular carcinoma. Liver
transplantation has evolved from an experimental life-saving procedure to a standard therapy for end-stage liver
disease. This conference will offer cutting edge technology presentations on recent advances in hepatology.
Maxwell M. Chait completed his M.D. degree at the age of 25 from the University of California School of Medicine at San
Francisco. He is a fellow of several prestigious organizations, including the American College of Physicians, American College
of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a
practicing gastroenterologist in the faculty of the Columbia University College of Physicians and Surgeons. He has authored more
than 40 publications in reputed journals. He is the editor-in-chief of the Journal of Liver Disease and Transplantation and serves on
the editorial board of the World Journal of Gastrointestinal Endoscopy.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals